Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Synthetic cathinones: chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as "bath salts" or "plant food".
- M. Coppola, R. Mondola
- Chemistry, Medicine
- Toxicology letters
- 1 June 2012
In 2000s, many synthetic cathinones have received a renewed popularity as designer drugs of abuse, particularly among young people. Despite being marketed as "bath salts" or "plant food" and labeled… Expand
3,4-methylenedioxypyrovalerone (MDPV): chemistry, pharmacology and toxicology of a new designer drug of abuse marketed online.
- M. Coppola, R. Mondola
- Medicine
- Toxicology letters
- 5 January 2012
The illicit marketplace of substances of abuse continually offers for sale legal alternatives to controlled drugs to a large public. In recent years, a new group of designer drugs, the synthetic… Expand
Methoxetamine: from drug of abuse to rapid-acting antidepressant.
- M. Coppola, R. Mondola
- Medicine, Biology
- Medical hypotheses
- 1 October 2012
Methoxetamine is a dissociative anaesthetic showing pharmacodynamic similarities with its analogue ketamine, a medication with demonstrated rapid-acting antidepressant effects. Like ketamine and… Expand
AH-7921: a new synthetic opioid of abuse.
- M. Coppola, R. Mondola
- Medicine
- Drug and alcohol review
- 2015
4,4'-DMAR: chemistry, pharmacology and toxicology of a new synthetic stimulant of abuse.
- M. Coppola, R. Mondola
- Medicine
- Basic & clinical pharmacology & toxicology
- 1 July 2015
In recent years, the spread of new psychoactive substances has dramatically increased in term of availability of both number of compounds and chemical families. In November 2012,… Expand
Research chemicals marketed as legal highs: the case of pipradrol derivatives.
- M. Coppola, R. Mondola
- Medicine
- Toxicology letters
- 7 July 2012
Between 1997 and 2011, more than 200 new substances were notified through the early-warning system, with the record number of 49 novel molecules reported in 2011. The pattern of acute toxicity… Expand
JWH-122 Consumption Adverse Effects: A Case of Hallucinogen Persisting Perception Disorder Five-Year Follow-Up
- M. Coppola, R. Mondola
- Medicine
- Journal of psychoactive drugs
- 25 April 2017
ABSTRACT Synthetic cannabinoid receptor agonists are a heterogeneous group of psychotropic drugs functionally related to Δ9-tetrahydrocannabinol. These substances, marketed as cannabis substitutes,… Expand
MT-45: a new, dangerous legal high.
- M. Coppola, R. Mondola
- Medicine
- Journal of opioid management
- 1 September 2014
Epidemiological data confirm that the use of new psychoactive substances is on the rise around the world.1 Numerous reports have described medical emergencies associated with the consumption of… Expand
Bromo-DragonFly: Chemistry, Pharmacology and Toxicology of a Benzodifuran Derivative Producing LSD-Like Effects
- M. Coppola, R. Mondola
- Chemistry
- 17 September 2012
Bromo-DragonFly is a potent and long-acting psychedelic drug producing both LSD-like effects and amphetamine activation. This drug appeared within the recreational drug market in the early 2000s,… Expand
Potential action of betel alkaloids on positive and negative symptoms of schizophrenia: A review
- M. Coppola, R. Mondola
- Psychology, Medicine
- Nordic journal of psychiatry
- 27 March 2012
Background: The Areca catechu Linn. is the fourth most used drug in the world after nicotine, ethanol and caffeine. This plant contains nine alkaloids with muscarinic and nicotinic action, which… Expand